Best Grants for Preschools in New York

The IATSE Local 798 Fund offers emergency financial assistance to performing arts and entertainment professionals facing unexpected critical needs. This support helps cover essential living expenses, including housing, utilities, and healthcare, to prevent eviction or service shut-offs. Eligible applicants must be union members for at least two years and have experienced unforeseen financial hardship due to circumstances beyond their control, such as injury or natural disasters.

The Metabolic Dysfunction-Associated Steatohepatitis Fund, established by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients facing chronic illnesses. It provides critical support for expenses related to prescription copays, insurance premiums, and transportation for treatment. With a maximum award of $8,000, the fund ensures that individuals can access necessary healthcare services without financial strain. This initiative emphasizes the commitment to improving health outcomes for those affected by metabolic dysfunction-associated steatohepatitis.

The Mantle Cell Lymphoma Fund, managed by the HealthWell Foundation, provides financial assistance to underinsured patients diagnosed with Mantle Cell Lymphoma. The fund covers prescription drug copays and Medicare Part B premiums, with a maximum award of $8,500. Eligible patients must have insurance that covers their medication and meet specific income guidelines. The foundation aims to reduce financial barriers to essential treatments, ensuring that patients receive necessary care without undue financial strain.

The HealthWell Foundation's Inborn Metabolic or Genetic Bile Acid Deficiency Vitamins and Supplements Fund provides essential financial assistance for individuals facing significant health challenges. By covering copays, deductibles, and related expenses, the fund aims to alleviate the financial burden on underinsured patients. With a commitment to enhancing healthcare access, the Foundation has awarded over $1.2 billion since its inception, ensuring that vital treatments remain accessible to those in need.

The Hyperoxaluria Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from hyperoxaluria, a condition characterized by excessive oxalate in urine. This fund assists with prescription drug copays and insurance premiums, providing vital support for treatments. In 2024 alone, HealthWell allocated over $1.2 billion in grants, ensuring access to essential medications for those in need. The organization is committed to improving healthcare access and reducing disparities for affected individuals.

The Emergency/Medical Workers Behavioral Health Fund aims to support emergency workers facing trauma and anxiety due to their roles. Established by the HealthWell Foundation, it provides financial assistance for treatment-related costs, including copayments for prescription drugs, counseling, and transportation. In 2024, the Foundation awarded over $1.2 billion to underinsured patients, ensuring no one is denied essential healthcare due to financial barriers. This initiative helps address the critical mental health needs of those who serve on the front lines.

The Dupuytren’s Disease Fund, managed by the HealthWell Foundation, aims to reduce financial barriers for underinsured patients suffering from Dupuytren's Disease. This fund provides assistance for prescription drug copays and insurance premiums related to treatment. With an average grant utilization of $1,650 over a 12-month period, the fund ensures that essential medications and therapies are affordable. HealthWell Foundation, a private non-profit, has helped over 1.1 million patients since 2004, demonstrating its commitment to healthcare access.

The Cushing's Disease or Cushing's Syndrome Fund, operated by the HealthWell Foundation, provides vital financial assistance to underinsured patients facing high medical costs associated with these conditions. The fund covers co-payments, insurance premiums, and necessary treatments, ensuring that patients receive the care they need without financial burden. With an average grant utilization of $3,000 over twelve months, this fund aims to alleviate the challenges of treatment accessibility, supporting both physical and mental health for those affected.

The Congenital Sucrase-Isomaltase Deficiency Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from this genetic disorder. By providing assistance with prescription drugs and treatment costs, the fund ensures that vital medications are accessible, allowing patients to manage their condition effectively. In 2024, the Foundation is expected to award over $1.2 billion in grants, showcasing its commitment to enhancing healthcare access for those in need.

The Chronic Lymphocytic Leukemia Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients battling chronic lymphocytic leukemia (CLL). This fund provides essential support for prescription copays and premiums, ensuring that patients can access necessary treatments without the stress of financial constraints. Since its inception, the foundation has awarded over $1.2 billion in grants, helping more than 1.1 million patients. The initiative emphasizes the importance of accessible healthcare and aims to improve the quality of life for those affected by this condition.

The Cancer-Related Behavioral Health Fund, established by the HealthWell Foundation, provides financial assistance to individuals diagnosed with cancer for behavioral health treatments. This fund covers costs associated with prescription drugs, counseling services, and transportation. Aiming to alleviate financial burdens, it ensures that underinsured patients can access necessary care without delay. In 2024, the foundation awarded over $1.2 billion, emphasizing its commitment to improving health outcomes for cancer patients across the United States.

The Blepharitis Fund, managed by the HealthWell Foundation, aims to alleviate financial barriers for underinsured patients suffering from blepharitis, an inflammatory condition of the eyelids. This program assists with prescription drug copays and insurance premiums, covering up to $3,500 annually for treatments. With a mission to ensure no patient is deprived of necessary healthcare due to financial constraints, the HealthWell Foundation has provided over $1.2 billion in grants, supporting more than 1.1 million patients since its inception.

The ANCA-Assoc Vasculitis and Granulomatosis with Polyangiitis Fund, established by the HealthWell Foundation, aims to reduce financial barriers for underinsured patients suffering from this rare and serious condition. The fund assists with copays, premiums, and out-of-pocket expenses related to treatment, ensuring that affected individuals have access to necessary medications. With over $1.2 billion in grants awarded since 2004, the foundation has helped over 1.1 million patients access critical healthcare services.

The Amyotrophic Lateral Sclerosis Fund, managed by HealthWell Foundation, aims to alleviate financial barriers for underinsured patients battling ALS, a progressive neurodegenerative disease. The fund provides financial assistance for prescription copays, insurance premiums, and related healthcare expenses, ensuring patients can access vital treatments. With an average grant utilization of $3,000 over twelve months, the fund exemplifies HealthWell's commitment to ensuring no patient is denied necessary healthcare due to cost. Since 2004, HealthWell has awarded over $1.2 billion in grants, supporting more than 1.1 million patients.

The Amyloidosis Fund, managed by the HealthWell Foundation, provides essential financial assistance to underinsured patients facing treatment costs for Amyloidosis. The program covers prescription copays, insurance premiums, and related expenses, ensuring that patients can access necessary medications without financial strain. With a maximum award of $8,000, the fund aims to alleviate the burden of healthcare costs for those diagnosed with this complex disease, promoting better health outcomes and quality of life for patients across the United States.

The Alagille Syndrome Vitamins and Supplements Fund, managed by the HealthWell Foundation, offers financial assistance to patients suffering from Alagille Syndrome. This fund helps cover the costs of essential vitamins and supplements needed for treatment. With a maximum award of $1,500, the program aims to reduce financial barriers for underinsured individuals, ensuring they receive the necessary support to manage their health, thereby enhancing their quality of life.

The PLTW Launch - New Program initiative, sponsored by Burns & McDonnell, aims to enhance STEM education by providing grants to eligible schools within specific U.S. counties. Schools must implement PLTW modules over two academic years, ensuring access to real-world learning experiences for students, particularly those from low-income backgrounds. This program emphasizes the importance of empowering educators and fostering student engagement in STEM fields to prepare them for future careers.

The PLTW Launch - Program Expansion initiative by Burns & McDonnell aims to enhance access to STEM education in U.S. schools. This program focuses on empowering students by providing real-world learning experiences and essential skills. Grants will support schools in expanding PLTW programs during the 2026-2027 academic year, benefiting students from underserved communities. By fostering a deeper understanding of STEM, the initiative seeks to inspire the next generation of innovators and problem solvers.

The PLTW Gateway - New Program, in partnership with Burns & McDonnell, aims to enhance student engagement in STEM by providing teachers with essential resources and support. Starting in the 2026-2027 academic year, eligible schools can apply for grants to introduce and expand PLTW programs, fostering real-world skills through applied learning. This initiative targets schools with significant free and reduced-price lunch populations, promoting equity in education across various U.S. counties.

The PLTW Gateway - Program Expansion initiative, led by Burns & McDonnell in partnership with Project Lead The Way (PLTW), aims to enhance STEM education by increasing access to PLTW programs for students in eligible communities. This program empowers students through real-world applied learning experiences, promoting essential skills for college and careers. Grants will support schools in expanding their existing PLTW Gateway programs starting in the 2026-2027 academic year, fostering a brighter future through education.

The USTA Player Development Excellence Grant supports aspiring U.S. tennis players by providing financial assistance based on performance and potential. Grants of up to $12,000 are awarded to players who meet specific criteria, encouraging their development into top 100 professionals. By utilizing USTA facilities and coaching, players can maximize their growth. The program aims to nurture young talent and ensure they have the resources necessary to succeed in competitive tennis.

The GO Queens Grant, funded by the Howard Gilman Foundation, aims to support Queens-based performing arts and culture organizations with unrestricted $10,000 grants. Targeted at nonprofits with annual budgets under $250,000, this initiative promotes growth and community engagement. Eligible organizations must focus on the performing arts, demonstrate nonprofit status, and have been active for at least a year. This funding is vital for general operational support, helping organizations recover post-COVID and enhance their contributions to the arts in Queens.

The CIRI Foundation offers the Higher Education Scholarship to support Alaska Native students pursuing post-secondary education. Scholarships provide $200 per credit hour for undergraduates and $400 for graduates, with a maximum of $9,000 per year. Eligible applicants must be CIRI shareholders or descendants, maintain a minimum 2.0 GPA, and be enrolled in accredited institutions. This initiative aims to enhance educational opportunities and promote cultural heritage.

The CIRI Foundation offers the Career Technical Education Scholarship to support Alaska Native beneficiaries pursuing post-secondary education. This scholarship provides up to $9,000 per year for educational expenses, including tuition and required supplies. Eligible applicants must be CIRI original shareholders or descendants, possess a high school diploma or GED, and maintain a minimum GPA. The foundation aims to promote self-sufficiency and the cultural legacy of Alaska Natives through education.

The CIRI Foundation, established in 1982, promotes education and economic self-sufficiency for Alaska Natives through scholarships like the Cap Lathrop Scholarship. This award offers up to $2,000 to full-time students pursuing degrees in fields such as business, engineering, and media. Eligible applicants must be Alaska Native shareholders or descendants, maintain a minimum 3.0 GPA, and intend to work in Alaska's broadcast industry. The scholarship supports both educational and personal expenses.

The Achievement Annual Scholarship, offered by the CIRI Foundation, supports Alaska Native students pursuing higher education. This merit-based scholarship awards up to $8,000 for one academic year, covering direct educational costs and personal expenses. Applicants must maintain a minimum 3.0 GPA and be enrolled full-time in a 4-year undergraduate or graduate program. The scholarship aims to promote academic excellence and career development while honoring the cultural legacy of Alaska Natives.

The Vascular Care for the Underserved Project Grants, funded by the Society for Vascular Surgery Foundation, aim to address disparities in vascular care for women. With a grant of $20,000, this initiative focuses on enhancing access, inclusion, and gender-specific research in vascular health. It supports innovative projects that aim to improve care delivery to underserved women and ensure equitable representation in vascular research, ultimately aiming to advance health outcomes and address historical exclusions in clinical studies.